Non Small Cell Lung Cancer Patients Treated With Erlotinib Six Months or Longer

NCT01522833 · clinicaltrials.gov ↗
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

SCRI Development Innovations, LLC

Collaborators